Page last updated: 2024-08-24

azimilide and Coronary Heart Disease

azimilide has been researched along with Coronary Heart Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grönefeld, GC; Hohnloser, SH1
Connolly, SJ; Kerr, CR; Kowey, P; Page, RL; Pritchett, EL; Ruda, MY; Ruzyllo, W; Wilkinson, WE1
SoRelle, R1

Reviews

1 review(s) available for azimilide and Coronary Heart Disease

ArticleYear
[Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Deutsche medizinische Wochenschrift (1946), 2002, Oct-25, Volume: 127, Issue:43

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hydantoins; Imidazoles; Imidazolidines; Meta-Analysis as Topic; Piperazines; Placebos; Primary Prevention; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Risk Factors; Time Factors

2002

Trials

1 trial(s) available for azimilide and Coronary Heart Disease

ArticleYear
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
    The American journal of cardiology, 2006, Jul-15, Volume: 98, Issue:2

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Confidence Intervals; Coronary Disease; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Hydantoins; Imidazolidines; Male; Middle Aged; Piperazines; Tachycardia, Paroxysmal; Treatment Outcome

2006

Other Studies

2 other study(ies) available for azimilide and Coronary Heart Disease

ArticleYear
Electrophysiology test may predict SCD (sudden cardiac death) risk: investigators induce VT in CAD patients.
    Patient-focused care and satisfaction, 1999, Volume: 7, Issue:8

    Topics: Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden, Cardiac; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Piperazines; Risk Assessment; Tachycardia, Ventricular; United States

1999
Cardiovascular news.
    Circulation, 2001, Nov-27, Volume: 104, Issue:22

    Topics: Acetanilides; Angina, Unstable; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Disease; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinolytic Agents; Fondaparinux; Humans; Hydantoins; Imidazoles; Imidazolidines; Multicenter Studies as Topic; Myocardial Infarction; Nicorandil; Piperazines; Polysaccharides; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome

2001